NanoVibronix Balance Sheet Health
Financial Health criteria checks 4/6
NanoVibronix has a total shareholder equity of $4.0M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $6.7M and $2.7M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$3.28m |
| Equity | US$3.99m |
| Total liabilities | US$2.69m |
| Total assets | US$6.67m |
Recent financial health updates
Recent updates
Most Shareholders Will Probably Find That The Compensation For NanoVibronix, Inc.'s (NASDAQ:NAOV) CEO Is Reasonable
Dec 09
NanoVibronix receives extension to satisfy Nasdaq bid price requirement
Oct 19NanoVibronix rises 27% on approval of Uroshield for sale in UK by NHS internal supply chain contract
Sep 23Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?
Jul 08Will NanoVibronix (NASDAQ:NAOV) Spend Its Cash Wisely?
Mar 22Is NanoVibronix (NASDAQ:NAOV) In A Good Position To Deliver On Growth Plans?
Dec 01NanoVibronix: Portable Ultrasonic Therapeutic Devices
Sep 01NanoVibronix (NASDAQ:NAOV) Is In A Good Position To Deliver On Growth Plans
Aug 17NanoVibronix announces expansion of distribution pact for its ultrasound devices
Dec 11NanoVibronix secures $6M in equity capital
Dec 02NanoVibronix reports Q3 results
Nov 17Financial Position Analysis
Short Term Liabilities: NAOV's short term assets ($6.5M) exceed its short term liabilities ($2.5M).
Long Term Liabilities: NAOV's short term assets ($6.5M) exceed its long term liabilities ($232.0K).
Debt to Equity History and Analysis
Debt Level: NAOV is debt free.
Reducing Debt: NAOV had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: NAOV has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: NAOV has less than a year of cash runway if free cash flow continues to reduce at historical rates of 12% each year